Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy.
Smith DA, Bradshaw D, Mbisa JL, Manso CF, Bibby DF, Singer JB, Thomson EC, da Silva Filipe A, Aranday-Cortes E, Ansari MA, Brown A, Hudson E, Benselin J, Healy B, Troke P, McLauchlan J, Barnes E, Irving WL. Smith DA, et al. Among authors: troke p. J Viral Hepat. 2021 Sep;28(9):1256-1264. doi: 10.1111/jvh.13549. Epub 2021 Jun 8. J Viral Hepat. 2021. PMID: 34003556 Free article.
Interferon lambda 4 impacts the genetic diversity of hepatitis C virus.
Ansari MA, Aranday-Cortes E, Ip CL, da Silva Filipe A, Lau SH, Bamford C, Bonsall D, Trebes A, Piazza P, Sreenu V, Cowton VM; STOP-HCV Consortium; Hudson E, Bowden R, Patel AH, Foster GR, Irving WL, Agarwal K, Thomson EC, Simmonds P, Klenerman P, Holmes C, Barnes E, Spencer CC, McLauchlan J, Pedergnana V. Ansari MA, et al. Elife. 2019 Sep 3;8:e42463. doi: 10.7554/eLife.42463. Elife. 2019. PMID: 31478835 Free PMC article.
In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
Lavender H, Brady K, Burden F, Delpuech-Adams O, Denise H, Palmer A, Perkins H, Savic B, Scott S, Smith-Burchnell C, Troke P, Wright JF, Suhy D, Corbau R. Lavender H, et al. Among authors: troke p. Antimicrob Agents Chemother. 2012 Mar;56(3):1364-75. doi: 10.1128/AAC.05357-11. Epub 2011 Dec 27. Antimicrob Agents Chemother. 2012. PMID: 22203606 Free PMC article.
HIV-1 proteinase is required for synthesis of pro-viral DNA.
Baboonian C, Dalgleish A, Bountiff L, Gross J, Oroszlan S, Rickett G, Smith-Burchnell C, Troke P, Merson J. Baboonian C, et al. Among authors: troke p. Biochem Biophys Res Commun. 1991 Aug 30;179(1):17-24. doi: 10.1016/0006-291x(91)91327-9. Biochem Biophys Res Commun. 1991. PMID: 1652947
Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication.
Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, Mickanin C, Leighton-Davies J, Wilson CJ, Myer V, Cornellataracido I, Baryza J, Tallarico J, Joberty G, Bantscheff M, Schirle M, Bouwmeester T, Mathy JE, Lin K, Compton T, Labow M, Wiedmann B, Gaither LA. Borawski J, et al. Among authors: troke p. J Virol. 2009 Oct;83(19):10058-74. doi: 10.1128/JVI.02418-08. Epub 2009 Jul 15. J Virol. 2009. PMID: 19605471 Free PMC article.
Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.
Pang L, Zhao X, Dickens BL, Lim JT, Cook AR, Netea MG, Donnelly JP, Herbrecht R, Johnson EM, Maertens JA, Kullberg BJ, Troke PF, Marr KA, Chai LYA. Pang L, et al. Among authors: troke pf. Clin Microbiol Infect. 2020 Jun;26(6):781.e1-781.e8. doi: 10.1016/j.cmi.2019.10.019. Epub 2019 Oct 24. Clin Microbiol Infect. 2020. PMID: 31669427 Free article. Clinical Trial.
61 results